Molecular detection of multidrug-resistant tuberculosis among smear-positive pulmonary tuberculosis patients in Jigjiga town, Ethiopia

被引:23
|
作者
Brhane, Mussie [1 ,2 ]
Kebede, Ameha [3 ]
Petros, Yohannes [3 ]
机构
[1] Harar Hlth Res & Reg Lab, Dept TB Culture, Harar, Ethiopia
[2] Harar Hlth Res & Reg Lab, DST Lab, Harar, Ethiopia
[3] Haramaya Univ, Coll Computat & Nat Sci, Dept Biol, Haramaya, Ethiopia
来源
关键词
GenoType (R) MTBDRplus; isoniazid; multidrug-resistant tuberculosis; rifampicin; smear-positive pulmonary tuberculosis; ANTITUBERCULOSIS DRUG-RESISTANCE; MYCOBACTERIUM-TUBERCULOSIS; ADDIS-ABABA; STRAINS; RIFAMPICIN; PATTERNS;
D O I
10.2147/IDR.S127903
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Molecular methods that target drug resistance mutations are suitable approaches for rapid drug susceptibility testing to detect multidrug-resistant tuberculosis (MDR-TB). The aim of the study was to determine MDR-TB cases and to analyze the frequency of gene mutations associated with rifampicin (RIF) and/or isoniazid (INH) resistance of Mycobacterium tuberculosis among smear-positive pulmonary tuberculosis patients. Methods: Institution-based cross-sectional study design was employed. Sputum specimens were collected, and using a pretested questionnaire, data for associated risk factors for drug resistance were collected from 105 consecutive smear-positive pulmonary tuberculosis patients in Karamara General Hospital. Specimens were transported to Harar Health Research and Regional Laboratory, Harar, where molecular drug susceptibility testing was performed using GenoType (R) MTBDRplus assay. Results: Of the total 105 sputum specimens, 98 (93.3%) gave interpretable results, in which 67 (68.4%) were new cases and 31 (31.6%) were previously treated cases. Of these, 80 (81.6%) were sensitive to both drugs and 18 (18.4%) were resistant to RIF and/or INH. The prevalences of MDR-TB in total cases, new, and previously treated cases were 10 (10.2%), 3 (4.5%), and 7 (22.6%), respectively. Among the ten total RIF-resistant specimens, eight (80%) had resulted because of absence of rpoB WT8 and presence of MUT3 and in all specimens, the amino acids changed were Ser531Lue. Of the 18 total INH-resistant specimens, 15 (83.3%) had mutations in the katG gene (katG MUT1, Ser315Thr1), indicating high-level resistance, while 3 (14.7%) had mutations in the inhA promoter gene (Cys15Thr), indicating low-level resistance. Conclusion: Among the mutations associated with resistance to RIF and INH, the majority were in codon 531 of the rpoB gene and codon 315 of the katG gene. Relatively high prevalence of MDR-TB was observed in the study.
引用
收藏
页码:75 / 83
页数:9
相关论文
共 50 条
  • [1] Rapid diagnosis of multidrug-resistant smear-positive pulmonary tuberculosis
    Lau, Ricky W. T.
    Ho, Pak-Leung
    Kao, Richard Y. T.
    Siu, Gilman K. H.
    Cheng, Vincent C. C.
    Yuen, Kwok-Yung
    Yam, Wing-Cheong
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2010, 35 (02) : 202 - 204
  • [2] Timely detection of multidrug-resistant Mycobacterium tuberculosis directly from smear-positive respiratory specimens
    Boegli-Stuber, K.
    Lechenne, B.
    Hilty, A.
    Bodmer, T.
    SWISS MEDICAL WEEKLY, 2008, 138 : 22S - 23S
  • [3] Determinants of treatment adherence among smear-positive pulmonary tuberculosis patients in southern Ethiopia
    Shargie, Estifanos Biru
    Lindtjorn, Bernt
    PLOS MEDICINE, 2007, 4 (02) : 280 - 287
  • [4] Trends in sputum smear conversion among smear-positive pulmonary tuberculosis patients
    Acquah, S. E. K.
    Quaye, L.
    Walana, W.
    Vicar, E. K.
    Osei, Y. N.
    Amedor, C.
    Yahaya, A. I.
    Ziem, J. B.
    JOURNAL OF MEDICAL AND BIOMEDICAL SCIENCE, 2015, 4 (01): : 24 - 33
  • [5] Prevalence of smear-positive pulmonary tuberculosis in a rural district of Ethiopia
    Shargie, EB
    Yassin, MA
    Lindtjorn, B
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2006, 10 (01) : 87 - 92
  • [6] Tuberculosis treatment outcome and associated factors among smear-positive pulmonary tuberculosis patients in Afar, Eastern Ethiopia: a retrospective study
    Zenebe, Tizazu
    Tefera, Ermias
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2016, 20 (06): : 635 - 636
  • [7] Registration and treatment of patients with smear-positive pulmonary tuberculosis
    Nyirenda, T
    Harries, AD
    Banerjee, A
    Salaniponi, FM
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 1998, 2 (11) : 944 - 945
  • [8] SYMPTOMS OF PULMONARY TUBERCULOSIS IN CONSECUTIVE SMEAR-POSITIVE CASES TREATED IN ETHIOPIA
    TEKLU, B
    TUBERCLE AND LUNG DISEASE, 1993, 74 (02): : 126 - 128
  • [9] Treatment outcome of smear-positive pulmonary tuberculosis patients in Tigray Region, Northern Ethiopia
    Gebretsadik Berhe
    Fikre Enquselassie
    Abraham Aseffa
    BMC Public Health, 12
  • [10] Treatment outcome of smear-positive pulmonary tuberculosis patients in Tigray Region, Northern Ethiopia
    Berhe, Gebretsadik
    Enquselassie, Fikre
    Aseffa, Abraham
    BMC PUBLIC HEALTH, 2012, 12